Further analysis of the T cell receptor gamma/delta+ peripheral lymphocyte subset. The V delta 1 gene segment is expressed with either C alpha or C delta.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMC 2187822)

Published in J Exp Med on April 01, 1990

Authors

C Miossec1, F Faure, L Ferradini, S Roman-Roman, S Jitsukawa, S Ferrini, A Moretta, F Triebel, T Hercend

Author Affiliations

1: Laboratoire d'Immunologie Cellulaire, Institut Gustave-Roussy, Villejuif, France.

Articles citing this

CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J Exp Med (1991) 1.96

A distinct wave of human T cell receptor gamma/delta lymphocytes in the early fetal thymus: evidence for controlled gene rearrangement and cytokine production. J Exp Med (1990) 1.41

Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR. J Immunol (2008) 1.39

Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). J Clin Invest (1991) 1.36

Gamma delta T cell receptor-positive cells of the human gastrointestinal mucosa: occurrence and V region gene expression in Heliobacter pylori-associated gastritis, coeliac disease and inflammatory bowel disease. Clin Exp Immunol (1991) 1.22

Enhancer-dependent and -independent steps in the rearrangement of a human T cell receptor delta transgene. J Exp Med (1994) 1.19

Lipid and small-molecule display by CD1 and MR1. Nat Rev Immunol (2015) 1.07

Divergent evolution of T cell repertoires: extensive diversity and developmentally regulated expression of the sheep gamma delta T cell receptor. EMBO J (1993) 1.05

Autoaggressive myocytotoxic T lymphocytes expressing an unusual gamma/delta T cell receptor. J Exp Med (1992) 1.01

Human gamma delta T cells: Evolution and ligand recognition. Cell Immunol (2015) 0.90

T cell target 1 (TCT.1): a novel target molecule for human non-major histocompatibility complex-restricted T lymphocytes. J Exp Med (1990) 0.87

Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS. J Virol (1996) 0.86

Unbiased analysis of TCRα/β chains at the single-cell level in human CD8+ T-cell subsets. PLoS One (2012) 0.86

The molecular bases of δ/αβ T cell-mediated antigen recognition. J Exp Med (2014) 0.84

Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency. Clin Exp Immunol (1993) 0.84

Reduction in T gamma delta cell numbers and alteration in subset distribution in systemic lupus erythematosus. Clin Exp Immunol (1991) 0.84

Surface expression of functional T cell receptor chains formed by interlocus recombination on human T lymphocytes. J Exp Med (1994) 0.83

Characterization of human αβTCR repertoire and discovery of D-D fusion in TCRβ chains. Protein Cell (2014) 0.81

Selective activation of gamma/delta + T cell clones by single anti-CD2 antibodies. J Exp Med (1991) 0.79

Human Peripheral CD4(+) Vδ1(+) γδT Cells Can Develop into αβT Cells. Front Immunol (2014) 0.79

TCT.1, a target molecule for gamma/delta T cells, is encoded by an immunoglobulin superfamily gene (Blast-1) located in the CD1 region of human chromosome 1. J Exp Med (1991) 0.76

Articles cited by this

Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature (1989) 3.79

The adult T-cell receptor delta-chain is diverse and distinct from that of fetal thymocytes. Nature (1988) 3.43

A new T-cell receptor gene located within the alpha locus and expressed early in T-cell differentiation. Nature (1987) 3.08

Immunochemical proof that a novel rearranging gene encodes the T cell receptor delta subunit. Science (1987) 2.93

Two tandemly organized human genes encoding the T-cell gamma constant-region sequences show multiple rearrangement in different T-cell types. Nature (1985) 2.92

T-cell receptor delta gene rearrangements in early thymocytes. Nature (1988) 2.88

Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor. J Exp Med (1988) 2.86

Rearrangement of two distinct T-cell gamma-chain variable-region genes in human DNA. Nature (1986) 2.58

A gamma-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity. Nature (1987) 2.48

New subgroups in the human T cell rearranging V gamma gene locus. EMBO J (1987) 2.42

Identification of putative human T cell receptor delta complementary DNA clones. Science (1987) 2.29

A novel subset of human lymphocytes with a T cell receptor-gamma complex. J Exp Med (1987) 2.12

Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature (1983) 1.93

A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity. Nature (1986) 1.90

Identification and sequence of a fourth human T cell antigen receptor chain. Nature (1988) 1.81

A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes. Eur J Immunol (1988) 1.76

A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). J Exp Med (1988) 1.71

Diversity and structure of human T-cell receptor alpha-chain variable region genes. Proc Natl Acad Sci U S A (1987) 1.69

Genetic polymorphism and exon changes of the constant regions of the human T-cell rearranging gene gamma. Proc Natl Acad Sci U S A (1986) 1.66

Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody. J Exp Med (1988) 1.62

A unique V-J-C-rearranged gene encodes a gamma protein expressed on the majority of CD3+ T cell receptor-alpha/beta- circulating lymphocytes. J Exp Med (1988) 1.61

Sequence and organization of the diversity, joining, and constant region genes of the human T-cell delta-chain locus. Proc Natl Acad Sci U S A (1988) 1.53

Human T-cell-receptor delta chain: genomic organization, diversity, and expression in populations of cells. Proc Natl Acad Sci U S A (1988) 1.53

T cell receptor-gamma and -delta genes preferentially utilized by adult thymocytes for the surface expression. J Immunol (1989) 1.50

Characterization of human peripheral lymphocytes expressing the CD3-gamma/delta complex with anti-receptor monoclonal antibodies. J Immunol (1988) 1.40

Characterization of a third form of the human T cell receptor gamma/delta. J Exp Med (1988) 1.38

Rearrangements to the JP1, JP and JP2 segments in the human T-cell rearranging gamma gene (TRG gamma) locus. FEBS Lett (1987) 1.37

T cells expressing gamma delta chain receptors in rheumatoid arthritis. J Autoimmun (1988) 1.32

Human T cell gamma chain joining regions and T cell development. J Immunol (1987) 1.27

Diversity and structure of human T cell receptor delta chain genes in peripheral blood gamma/delta-bearing T lymphocytes. J Exp Med (1989) 1.22

Structural and serological heterogeneity of gamma/delta T cell antigen receptor expression in thymus and peripheral blood. Eur J Immunol (1988) 1.22

Diversity and organization of human T cell receptor delta variable gene segments. J Exp Med (1989) 1.21

Predominant variable region gene usage by gamma/delta T cell receptor-bearing cells in the adult thymus. J Exp Med (1988) 1.09

The coagulation-kinin pathway of human plasma. Blood (1987) 1.06

Identification of a CD2- CD3+ T cell receptor-gamma+ peripheral blood lymphocyte subpopulation. J Immunol (1988) 0.96

Monoclonal antibodies which react with the T cell receptor gamma/delta recognize different subsets of CD3+WT31- T lymphocytes. Eur J Immunol (1989) 0.93

cDNA cloning of functional T cell receptor gamma/delta chains expressed in human peripheral blood lymphocytes. Eur J Immunol (1989) 0.90

Phenotypical heterogeneity among human T cell receptor gamma/delta-expressing clones derived from peripheral blood. Eur J Immunol (1989) 0.89

Use of a variable alpha region to create a functional T-cell receptor delta chain. Proc Natl Acad Sci U S A (1988) 0.87

Cloned CD3+ TcR alpha/beta- Ti gamma A- peripheral blood lymphocytes compared to the Ti gamma A+ counterparts: structural differences of the gamma/delta receptor and functional heterogeneity. Eur J Immunol (1988) 0.84

Articles by these authors

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57

LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med (2001) 5.71

Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J Immunol (1976) 4.64

Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med (1983) 4.47

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med (1998) 3.83

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity (1995) 3.72

Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science (1995) 3.19

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med (1998) 3.09

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med (1999) 3.08

Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor. J Exp Med (1988) 2.86

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity (1997) 2.71

p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med (1997) 2.70

Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med (1992) 2.69

NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol (1999) 2.59

Surface structures involved in target recognition by human cytotoxic T lymphocytes. Science (1982) 2.52

A gamma-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity. Nature (1987) 2.48

Characterization of an antigen expressed by human natural killer cells. J Immunol (1983) 2.44

Subpopulations of human peripheral T gamma delta lymphocytes. Immunol Today (1989) 2.39

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med (2000) 2.29

The human T-cell receptor. Annu Rev Immunol (1984) 2.23

CD3-negative lymphokine-activated cytotoxic cells express the CD3 epsilon gene. J Immunol (1988) 2.22

Allorecognition by NK cells: nonself or no self? Immunol Today (1992) 2.21

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med (1999) 2.17

Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations. J Exp Med (1983) 2.16

Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture. J Exp Med (1988) 2.14

A novel subset of human lymphocytes with a T cell receptor-gamma complex. J Exp Med (1987) 2.12

Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest (1997) 2.11

Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci U S A (1992) 2.08

Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans. J Exp Med (1992) 2.04

An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol (1992) 2.03

The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med (1996) 2.02

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med (1996) 2.00

Human natural killer cell receptors and co-receptors. Immunol Rev (2001) 1.94

Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature (1983) 1.93

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol (2001) 1.93

Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol (1997) 1.92

Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex. J Exp Med (1985) 1.92

A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity. Nature (1986) 1.90

Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90

Surface markers of cloned human T cells with various cytolytic activities. J Exp Med (1981) 1.87

NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J Exp Med (2001) 1.86

Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature (1985) 1.85

Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture. J Exp Med (1988) 1.84

Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol (1997) 1.84

Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones. Science (1985) 1.83

Human natural killer cells: origin, clonality, specificity, and receptors. Adv Immunol (1994) 1.83

LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med (1990) 1.83

SOFA--an open source framework for medical simulation. Stud Health Technol Inform (2007) 1.81

Human T lymphocyte subpopulations: studies of the mechanism by which T cells bearing Fc receptors for IgG suppress T-dependent B cell differentiation induced by pokeweed mitogen. J Immunol (1979) 1.80

A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes. Eur J Immunol (1988) 1.76

Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci (2001) 1.74

T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. Clin Exp Immunol (1989) 1.72

A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). J Exp Med (1988) 1.71

The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol (1997) 1.69

HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci U S A (1998) 1.67

Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture. J Exp Med (1981) 1.66

2B4 functions as a co-receptor in human NK cell activation. Eur J Immunol (2000) 1.65

Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells. J Exp Med (1990) 1.63

Sequences and diversity of human T cell receptor beta chain variable region genes. J Exp Med (1986) 1.62

Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function. J Exp Med (1983) 1.62

A unique V-J-C-rearranged gene encodes a gamma protein expressed on the majority of CD3+ T cell receptor-alpha/beta- circulating lymphocytes. J Exp Med (1988) 1.61

Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets. Hum Immunol (1981) 1.57

Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol (2007) 1.57

Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood. J Immunol (1982) 1.56

Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B. Proc Natl Acad Sci U S A (1990) 1.54

Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A (1999) 1.53

Natural killer cell activity and delivery: possible influence of cortisol and anesthetic agents. A study on newborn cord blood. Biol Neonate (1999) 1.53

Studies on the human T cell receptor alpha/beta variable region genes. II. Identification of four additional V beta subfamilies. Eur J Immunol (1991) 1.53

Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol (1995) 1.51

Transmembrane signalling via the T11-dependent pathway of human T cell activation. Evidence for the involvement of 1,2-diacylglycerol and inositol phosphates. Eur J Immunol (1987) 1.49

Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J Exp Med (1992) 1.48

Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone (2001) 1.48

Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation. Proc Natl Acad Sci U S A (1987) 1.47